CD4+ TCRαβ+ T-cell clones derived shortly after allogeneic bone marrow transplantation: Theophyllamine and verapamil inhibit proliferation of functionally heterogeneous T-cells
Authors:
- 1 July 1992
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 14 (5) , 783-789
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- CD4+TCRαβ+ T-cells developing after allogeneic bone marrow transplantation in patients with chronic myelogenous leukaemia. Dipyridamole inhibits functionally heterogeneous T-cell clonesInternational Journal of Immunopharmacology, 1991
- Pentoxifylline and other methyl xanthines inhibit interleukin-2 receptor expression in human lymphocytesCellular Immunology, 1991
- Multidrug resistance: Clinical relevance in haematological malignanciesBlood Reviews, 1991
- T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1Nature, 1989
- Differential secretion of tumor necrosis factor-α and granulocyte/macrophage colony-stimulating factors but not interferon-γ from CD4 compared to CD8 human T cell clonesEuropean Journal of Immunology, 1989
- Theophylline and the immune response: In vitro and in vivo effectsClinical Immunology and Immunopathology, 1988
- Effect of Verapamil on T-Lymphocyte Activation in VitroScandinavian Journal of Immunology, 1985
- Voltage-gated potassium channels are required for human T lymphocyte activation.Journal of Experimental Medicine, 1984
- The effect of theophyllamine on T-lymphocyte activation in vitroClinical Immunology and Immunopathology, 1984
- Induction and separation of antigen-dependent T helper and T suppressor cells in manNature, 1978